Winter 2025
From artificial intelligence to tailor-made medicines, Scripps Research scientists weigh in on how the future of science and medicine will reshape health, disease and our everyday lives.
How science and innovation can mitigate future pandemics
Irene Khalek is on a quest to design a universal antivenom and protect people around the world from the deadliest snakebites.
Katja Lamia shares how our internal circadian clocks dictate the rhythm of our lives.
As Scripps Research marks the end of its first century and begins the next, one fact remains constant: science never stands still.
Helen L. Dorris, a longtime advocate and donor of Scripps Research, took this mission to heart. Her support for the institute began in 1999, after she made a monumental gift to establish the Harold L. Dorris Neurological Research Center, and then later the Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents. These centers became the basis of the now world-renowned Dorris Neuroscience Center (DNC), bringing together multidisciplinary scientists to investigate new approaches to treat illnesses of the nervous system.
On August 1, 2024, almost 80 new graduate students began their doctoral studies at Scripps Research’s Skaggs Graduate School of Chemical and Biological Sciences, continuing a steady growth trend since the program’s founding 35 years ago. While the student body today hovers around 400, back in the summer of 1989, it was just five pioneering graduate students who joined as the institute’s inaugural class.
On May 17, 2024, a record 59 graduate students earned their doctoral degrees from Scripps Research’s Skaggs Graduate School of Chemical and Biological Sciences, marking the largest graduating class since the school’s founding in 1989. Students in the Class of 2024 represent the entire biomedical research spectrum of the 32 faculty members who served as their advisors and mentors, and in whose labs the students completed doctoral studies. From neuroscience, immunology and structural biology, to chemistry, chemical biology and computational biology, the graduates completed
Scripps Research is welcoming nine new scientists who bring their expertise to advance crucial discoveries in human health. They aim to make significant strides in areas including HIV, cancer, inflammatory bowel disease, autoimmune disorders and much more.
Donna Blackmond, PhD, Scripps Research professor and the John C. Martin Endowed Chair in Chemistry, has been elected as a fellow of the Royal Society of the United Kingdom, one of the world’s oldest scientific academies.
Executive Vice President and Professor Eric Topol, MD, was featured in the inaugural 2024 TIME100 Health list of most influential people working in global health, recognizing those spearheading efforts to improve health worldwide through scientific research and innovation.
The American Institute of Chemists (AIC) has awarded Scripps Research President and CEO Pete Schultz, PhD, the 2024 AIC Gold Medal for his contributions in chemical and synthetic biology.
Li Ye, PhD, associate professor in the Departments of Neuroscience and Molecular Medicine and the Abide-Vividion Chair in Chemistry and Chemical Biology, has been named a Howard Hughes Medical Institute Investigator.
Xin Jin, PhD, Scripps Research assistant professor of neuroscience, has been named a Pew Scholar in the Biomedical Sciences. The Pew Scholars Program funds early-career scientists who demonstrate promise in the advancement of human health.
Three Scripps Research scientists have been named Prebys Research Heroes: associate chemistry professor Mia Huang, PhD; assistant neuroscience professor Xin Jin, PhD; and neuroscience professor Lisa Stowers, PhD.
Scripps Research advances scientific understanding, educates the scientists of tomorrow and impacts human health across the globe. We are science changing life.